SLN (STOCKS)
Silence Therapeutics Plc American Depository Share
$6.005000
+0.275000 (+4.80%)
Prev close: $5.730000
Company Information
- Exchange
- XNAS
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Iain Gladstone Ross
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $283.64M
- Employees
- 116
- P/E (TTM)
- -3.19
- P/B (TTM)
- 4.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$0.21 | $0.00 | +0.0000 | +0.00% |
|
Dec 2023 (Q4)
|
$-0.37 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $559.00K |
| Benefits Costs and Expenses | $89.16M |
| Cost Of Revenue | $215.00K |
| Costs And Expenses | $89.16M |
| Gross Profit | $344.00K |
| Operating Expenses | $91.42M |
| Research and Development | $67.75M |
| Other Operating Expenses | $23.67M |
| Operating Income/Loss | -$91.08M |
| Income/Loss From Continuing Operations After Tax | -$88.61M |
| Income/Loss From Continuing Operations Before Tax | -$88.60M |
| Income Tax Expense/Benefit | $11.00K |
| Income Tax Expense/Benefit, Current | $11.00K |
| Income Tax Expense/Benefit, Deferred | $11.00K |
| Net Income/Loss | -$88.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$88.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$88.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.63 |
| Diluted Earnings Per Share | -$0.63 |
| Basic Average Shares | 141,694,702 |
| Diluted Average Shares | 141,694,702 |
| Assets | $131.44M |
| Current Assets | $118.66M |
| Cash | $85.10M |
| Other Current Assets | $33.56M |
| Noncurrent Assets | $12.78M |
| Fixed Assets | $1.58M |
| Intangible Assets | $288.00K |
| Other Non-current Assets | $10.92M |
| Liabilities | $69.14M |
| Current Liabilities | $13.61M |
| Noncurrent Liabilities | $55.53M |
| Equity | $62.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $62.30M |
| Liabilities And Equity | $131.44M |
| Net Cash Flow From Operating Activities | -$62.27M |
| Net Cash Flow From Operating Activities, Continuing | -$62.27M |
| Net Cash Flow From Investing Activities | -$47.99M |
| Net Cash Flow From Investing Activities, Continuing | -$47.99M |
| Net Cash Flow From Financing Activities | $15.00K |
| Net Cash Flow From Financing Activities, Continuing | $15.00K |
| Exchange Gains/Losses | $195.00K |
| Net Cash Flow | -$110.05M |
| Net Cash Flow, Continuing | -$110.25M |
| Comprehensive Income/Loss | -$79.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$79.81M |
| Other Comprehensive Income/Loss | $8.80M |